Back to search
Postmenopausal Vulvovaginal Atrophy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Postmenopausal Vulvovaginal Atrophy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Postmenopausal Vulvovaginal Atrophy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to retrospectively identify the most prevalent symptoms of genitourinary syndrome of menopause (GSM) among postmenopausal wom…
Eligible patients will be randomized to treatment with Hyalo Gyn® gel or placebo, at the dose regimen of 1 application deeply in the vagina every 3 days (i.e. a…